Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.
about
Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute CorClinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients.Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes.Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.Bleeding complications in patients with acute coronary syndromes: are they important and how can we prevent them?Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation.Antithrombotic prophylaxis and therapy in renal failure.Anticoagulation in renal failure is safe and effective.[Acute coronary syndromes without ST segment elevation].
P2860
Q33523243-A1C333C4-F753-466E-9681-B785819280DFQ34255603-43152D5E-B2F0-43B1-A02A-15D0A2AA7086Q35111496-ECFA152E-7B12-490B-858C-2D381257216BQ37151458-C288189E-4453-46AE-B04A-3BA13CFE627BQ37490581-C08ABC57-DC28-4F07-9746-406012DE6A62Q37517937-A06091BE-9322-45A4-846E-C20C69EA1C53Q37844143-D3ED009E-76CB-41D2-8503-7A32F3CD2475Q38012078-6DC6DADA-992E-4D72-82F3-F9EDDA4489BFQ40962118-71018B2B-05BA-40FC-B267-C328E4AD5907Q42690717-BAE2D4DD-D92D-4A63-8406-85190DC65545Q42690754-F09B3404-7B2A-4701-BB88-7BB0EA86A86FQ46123306-53EAF260-63C4-4BB9-80C6-FA44AD4BEA82
P2860
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@en
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@nl
type
label
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@en
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@nl
prefLabel
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@en
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@nl
P2093
P2860
P356
P1476
Non-ST-segment elevation acute ...... stry of Acute Coronary Events.
@en
P2093
Christopher V Laufenberg
Dietrich Gulba
Enrique P Gurfinkel
GRACE Investigators
Giancarlo Agnelli
Jean-Philippe Collet
Jose López-Sendón
Martin Klutman
Neelam Gowda
P2860
P304
P356
10.1093/EURHEARTJ/EHI337
P577
2005-06-02T00:00:00Z